Global Liquid Biopsy Market Estimated to reach $1.75 billion at a CAGR of 24.3% by 2021
Research report by MarketDataForecast.com with in-depth analysis on Liquid Biopsy Market which provides information on market size, share, forecasts and company profiles for major industry participants 2016-2021
(EMAILWIRE.COM, January 19, 2017 ) Liquid Biopsy Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc.
View Report at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/
Liquid biopsies have been an advancement in cancer treatment. By means of a simple blood draw, liquid biopsies aim to replace needle biopsies of solid tumours, which can be expensive for the healthcare system as well as invasive and painful for patients. Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue
Get free sample report at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/request-sample
Liquid biopsies have grown in importance because, the genetic profile of tumours can affect how well they respond to a certain treatment. Increasing prevalence of various cancers such as lung cancer, breast cancer and prostate cancer is expected to drive growth of the liquid biopsy test market over the forecast period.
Request Customization at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/customize-report
Global Market for Liquid Biopsy is segmented By Type, Diagnostic Approach, End Users and Region.
1. By Cancer Type:
Lung Cancer
Pancreatic Cancer
Leukemia
Other Visceral Cancers
2. By Sample Type:
Blood
Urine
Plasma
Saliva
Cerebrospinal
3. By Diagnostic Approach:
Circulating Tumour cells (CTC)
Circulating Tumour DNA (ctDNA)
RNA in exosomes
Extra-Cellular Vesicles
4. By End Users:
Reference Laboratories
Hospital/Physician Laboratories
Academic and Research Centers
Other End Users
5. By Geography:
North America
Europe
Asia-Pacific
Latin America
Middle-East and Africa
Enquire before buying at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/inquire
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Buy this report at https://www.marketdataforecast.com/cart/buy-now/global-liquid-biopsy-market-950
Scope of the report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
About us:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
View Report at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/
Liquid biopsies have been an advancement in cancer treatment. By means of a simple blood draw, liquid biopsies aim to replace needle biopsies of solid tumours, which can be expensive for the healthcare system as well as invasive and painful for patients. Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue
Get free sample report at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/request-sample
Liquid biopsies have grown in importance because, the genetic profile of tumours can affect how well they respond to a certain treatment. Increasing prevalence of various cancers such as lung cancer, breast cancer and prostate cancer is expected to drive growth of the liquid biopsy test market over the forecast period.
Request Customization at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/customize-report
Global Market for Liquid Biopsy is segmented By Type, Diagnostic Approach, End Users and Region.
1. By Cancer Type:
Lung Cancer
Pancreatic Cancer
Leukemia
Other Visceral Cancers
2. By Sample Type:
Blood
Urine
Plasma
Saliva
Cerebrospinal
3. By Diagnostic Approach:
Circulating Tumour cells (CTC)
Circulating Tumour DNA (ctDNA)
RNA in exosomes
Extra-Cellular Vesicles
4. By End Users:
Reference Laboratories
Hospital/Physician Laboratories
Academic and Research Centers
Other End Users
5. By Geography:
North America
Europe
Asia-Pacific
Latin America
Middle-East and Africa
Enquire before buying at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/inquire
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Buy this report at https://www.marketdataforecast.com/cart/buy-now/global-liquid-biopsy-market-950
Scope of the report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analyzing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
About us:
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization thats trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results